1. Mechanisms underlying reversed TRAIL sensitivity in acquired bortezomib-resistant non-small cell lung cancer cells
   Leonie De Wilt et al, 2024, Cancer Drug Resistance CrossRef
2. The Role of Lipid Metabolism in Gastric Cancer
   Meng-Ying Cui et al, 2022, Frontiers in Oncology CrossRef
3. Preclinical optimization of a broad-spectrum anti-bladder cancer tri-drug regimen via the Feedback System Control (FSC) platform
   Qi Liu et al, 2015, Scientific Reports CrossRef
4. Role of Cholesterol and Lipid Rafts in Cancer Signaling: A Promising Therapeutic Opportunity?
   Rosa Vona et al, 2021, Frontiers in Cell and Developmental Biology CrossRef
5. Regulation of Death Receptor Signaling by S-Palmitoylation and Detergent-Resistant Membrane Micro Domains—Greasing the Gears of Extrinsic Cell Death Induction, Survival, and Inflammation
   Jürgen Fritsch et al, 2021, Cancers CrossRef
6. Analysis of Gene Expression of miRNA-106b-5p and TRAIL in the Apoptosis Pathway in Gastric Cancer
   Jéssica Pereira et al, 2020, Genes CrossRef
7. Fas/CD95, Lipid Rafts, and Cancer
   Faustino Mollinedo et al, 2017, TRAIL, Fas Ligand, TNF and TLR3 in Cancer CrossRef
8. New advances in targeted gastric cancer treatment
   Daniela Cornelia Lazăr et al, 2016, World Journal of Gastroenterology CrossRef